Genetic variability in serotonin receptor and transporter genes may influence risk for tardive dyskinesia in chronic schizophrenia

Psychiatry Res. 2011 Jun 30;188(1):175-6. doi: 10.1016/j.psychres.2010.10.006. Epub 2010 Nov 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Cysteine / genetics
  • Disease Susceptibility*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Movement Disorders / etiology
  • Movement Disorders / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Receptors, Serotonin, 5-HT3 / genetics*
  • Risk Factors
  • Schizophrenia / drug therapy
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Taiwan
  • Threonine / genetics

Substances

  • Antipsychotic Agents
  • HTR3A protein, human
  • Receptors, Serotonin, 5-HT3
  • Serotonin Plasma Membrane Transport Proteins
  • Threonine
  • Cysteine